• Vt. to get $1.1 million drug settlement
    November 17,2012
    • Email Article
    •  
    •  Print Article
     
    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.
    • Email Article
    •  
    •  Print Article
    2 Comments
    MORE IN Vermont News
    PHILADELPHIA — With his presidential campaign officially over, independent Sen. Full Story
    Sanders renews call for unity with Clinton
    MONTPELIER — Rep. Peter Welch, D-Vt. Full Story
    PHILADELPHIA — With his presidential campaign officially over, independent Sen. Full Story
    Sanders renews call for unity with Clinton
    More Articles